ABCA10: A Potential Drug Target and Biomarker for ABCA Transporters

Target Name: ABCA10

NCBI ID: G10349

ABCA10

ABCA10: A Potential Drug Target and Biomarker for ABCA Transporters

Abstract:

ABCA10 (ATP binding cassette subfamily A member 10, transcript variant 1) is a protein that plays a crucial role in intracellular signaling, particularly in the regulation of intracellular calcium levels. The ABCA10 gene has been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Although its functions and mechanisms of action are not yet fully understood, research has shown that it is involved in the regulation of multiple cellular processes, including cell signaling, DNA replication, and protein transport. As a result, ABCA10 has emerged as a promising drug target and biomarker for a variety of diseases.

Introduction:

The ABCA10 gene is a member of the ATP binding cassette (ABC) subfamily A, which is responsible for the regulation of intracellular signaling. The ABCA10 gene has four exons, and its corresponding transcript has five exons (1-5). The protein encoded by the ABCA10 gene is a 140 amino acid long protein that is highly conserved in its sequence and structure.

ABCA10 functions as an essential protein in various cellular processes, including intracellular signaling, DNA replication, and protein transport. Its functions and mechanisms of action are not yet fully understood, but research has shown that it is involved in the regulation of multiple cellular processes.

Disease association:

ABCA10 has been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, studies have shown that ABCA10 is involved in the regulation of cell signaling, DNA replication, and protein transport, which are crucial processes for the development and progression of cancer.

In addition, ABCA10 has also been linked to neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These diseases are characterized by the progressive loss of brain cells, which is believed to be caused by the build-up of toxic substances in the brain. Studies have shown that ABCA10 is involved in the regulation of the production and clearance of these toxic substances, which may contribute to the development and progression of these diseases.

Drug targeting:

ABCA10 has emerged as a promising drug target due to its involvement in various diseases. One of the primary goals of drug targeting is to identify small molecules that can modulate the activity of ABCA10 and improve its therapeutic potential.

Recent studies have shown that various small molecules have been shown to interact with ABCA10 and enhance its function. For example, studies have shown that inhibitors of the protein kinase C (PKC), a known interacting partner of ABCA10, can reduce the activity of ABCA10 and improve the sensitivity of cancer cells to chemotherapy.

Another study has shown that small molecules that can modulate the activity of ABCA10 can also enhance its ability to transport proteins across cell membranes. This may have implications for the treatment of diseases that are characterized by the accumulation of toxic substances in the body, such as neurodegenerative diseases.

Biomarker:

ABCA10 has also been shown to be a potential biomarker for various diseases. The ABCA10 gene has been shown to be involved in the regulation of intracellular signaling, which may be related to the production of diagnostic biomarkers.

Studies have shown that changes in the ABCA10 gene have been associated with the development of various diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, studies have shown that individuals with certain genetic variations in the ABCA10 gene are at increased risk for the development of certain diseases.

Conclusion:

In conclusion, ABCA10 is a protein that plays a crucial role in intracellular signaling and has been implicated in various diseases. Its functions and mechanisms of action are not yet fully understood, but research has shown that it is involved in the regulation of multiple cellular processes. As a result, ABCA10 has emerged as a promising drug target and biomarker for a variety of diseases. Further research is needed to fully understand its functions and potential uses in the treatment of these diseases.

Protein Name: ATP Binding Cassette Subfamily A Member 10

Functions: Probable transporter which may play a role in macrophage lipid transport and homeostasis

The "ABCA10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ABCA10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets